HAWK Biosystems

www.hawkbiosystems.com ↗ ·Derio ·Series A

HAWK Biosystems is a Derio-based (Bizkaia) biotech company specialising in precision oncology diagnostics. Its proprietary QF-Pro technology measures protein interactions directly in cells and FFPE tissue samples, for biomarker development in translational research and companion diagnostics, including predicting which cancer patients will respond to immunotherapy. It serves pharma companies and research groups, and distributes through partners such as Proquinorte in Spain and Portugal and Axonlab in Europe, with further partners in Australia and Canada. Founded in 2015 as Fastbase Solutions by scientists from the Francis Crick Institute and the Instituto Biofisika (UPV/EHU-CSIC), it was selected for the EIC Accelerator in 2024 (€2.5M grant plus up to €4.5M equity). It later closed a €3.5M round led by Inveready with the EIC Fund and the Basque Fund (SPRI Group), bringing total funding to about €12.5M.

Founded

2015

Founders

Total funds raised

€5.2M

SectorsBiotechnology, Precision oncology, Diagnostics, Spatial proteomics Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing

Suggest a correction

Founders

Banafshé Larijani

Co-founder

Fernando Aguirre

Founder & CEO

Peter J. Parker

Co-founder

Global models 5

PathAI

United States · www.pathai.com ↗

PathAI sells tissue-based biomarker analysis to pharma for translational research and companion diagnostics, including predicting response to immuno-oncology drugs, but it reads FFPE slides with AI where HAWK uses a molecular protein-interaction assay.

$255MComparable

Ultivue

United States · www.ultivue.com ↗

Like HAWK, Ultivue sells proprietary multiplex protein-biomarker assay kits for FFPE tissue and runs a contract research service for pharma immuno-oncology biomarker and companion-diagnostic work.

$100MComparable

Akoya Biosciences

United States · www.akoyabio.com ↗

Akoya sells spatial protein-phenotyping platforms and assays for FFPE tissue to pharma and research labs for translational immuno-oncology biomarker discovery and predicting immunotherapy response.

$85MComparable

Lunaphore Technologies

Switzerland · lunaphore.com ↗

Lunaphore sold multiplex tissue protein-biomarker technology for FFPE samples to pharma and research groups for translational oncology and diagnostic development, and was bought by Bio-Techne in 2023.

$83MComparable

Enable Medicine

United States · www.enablemedicine.com ↗

Enable Medicine provides spatial-proteomics tissue profiling and analysis to pharma partners for biomarker discovery and patient stratification in translational research.

$64MComparable

In the same niche 50 others

Most funded firstSee all 51 in Diagnostics & precision medicine testing →

Universal Diagnostics

Venture Debt · €24.1M

Biohope

Madrid

Unstaged equity · €15M

iPremom

Valencia

Seed · €15M

+44 more →

Investors 6

Open 5 in the directory as list →

Inveready

www.inveready.com

Led Series A 2026 Spain

Capital Cell

capitalcell.com

2 rounds · 2020–23 Spain

EIC Fund

eic.ec.europa.eu

Series A 2026 Luxembourg

Hasten Ventures

www.hasten.es ↗

Seed 2020 Spain No profile

www.seedcapitalbizkaia.eus

Public lender Spain

Funding rounds 4

·1 not counted

Date	Round	Amount	Lead
2026-10-21	Series A (estimated)	€3.5M	Inveready +2 more
2023-03-31	Seed (estimated)	approximately €760K	Lead not disclosed +1 more
2022-05-27	Seed (estimated)	approximately €200K	Lead not disclosed
2020-08-06	Seed (estimated)	€750K	Lead not disclosed +2 more

Not counted (1)

Not counted in totals

2024-03-13

Grant

€2.5M

Lead not disclosed

+1 more

News 7

Open as list →

Published	Article
2026-10-21	HAWK Biosystems raises €3.5M to take its cancer diagnostic to the clinic ↗ Dealroom News 2026-10-21
2026-03-06	HAWK Biosystems is coming to Germany ↗ Future Lab Innovations 2026-03-06
2025-12-30	La medicina de precisión de Hawk Biosystems, surgida de la UMH, cierra 2025 con presencia en EEUU y China y ya distribuye en 33 países ↗ Alicante Plaza 2025-12-30
2024-10-22	HAWK Biosystems, leader in Spatial Biology ↗ BioSPX 2024-10-22
2024-08-28	La spin-off de la UMH Hawk Biosystems se asocia con Axonlab International para su papel en Europa ↗ Alicante Plaza 2024-08-28
2024-03-13	Hawk Biosystems and Alias Robotics accelerate by obtaining the "EIC Accelerator" from the European Commission ↗ Bizkaia Science and Technology Park (parke.eus) 2024-03-13
2023-01-26	Hawk Biosystems busca inversión de 800.000 euros con Capital Cell para su proyecto en oncología ↗ Alicante Plaza 2023-01-26